BioMedSyn

Alethia Biotherapeutics, Inc. is a biopharmaceutical company focused on developing novel immunotherapies for the treatment of cancer. The company's website states that they are dedicated to advancing the science of personalized cancer immunotherapy to bring new treatment options to patients in need. On their website, Alethia Biotherapeutics, Inc. mentions that their expertise lies in the development of personalized cancer vaccines and cell therapies that harness the patient's immune system to target and destroy cancer cells. They also emphasize their commitment to precision medicine, utilizing cutting-edge technologies to tailor treatments to individual patients based on their specific cancer profile. In terms of their pipeline, Alethia Biotherapeutics, Inc. is currently focused on advancing their lead candidate through clinical development. They aim to conduct rigorous clinical trials to demonstrate the safety and efficacy of their immunotherapies in different cancer indications. On Clinicaltrials.com, there is information about ongoing clinical trials related to Alethia Biotherapeutics, Inc.'s immunotherapy candidates. These trials are designed to evaluate the potential of their treatments in various cancer types and patient populations. Overall, Alethia Biotherapeutics, Inc. is a biopharmaceutical company with a strong focus on personalized cancer immunotherapy. They are actively engaged in advancing their science and pipeline through clinical development to address the unmet needs of cancer patients.

Genelux Corporation, iOnctura SA, ImmunityBio, Inc., Achieve Life Sciences, Inc., Bayer HealthCare Pharmaceuticals Inc., Cardiff Oncology, Inc., Beijing Biostar Pharmaceuticals Co. Ltd., Hikma Pharmaceuticals Plc, GSK plc, Aeterna Zentaris Inc., Eli Lilly and Company, Telik, Spectrum Pharmaceuticals, Inc., Simcere Pharmaceutical Group Limited, Sanofi, Amgen Inc., MacroGenics, Inc., AstraZeneca PLC, Genmab A/S, LIDDS AB, NRG Therapeutics Ltd., NeoTX Therapeutics Ltd., Infinity Pharmaceuticals, Inc., Revolution Medicines, Inc., Ionis Pharmaceuticals, Inc., Bristol-Myers Squibb Company, BeyondSpring Inc., Inxmed Co., Ltd, BioNumerik Pharmaceuticals, Inc., Mirati Therapeutics, Inc., Genentech, Inc., OncoC4, Inc., Seagen Inc., Astellas Pharma, Inc., Hummingbird Bioscience Pte Ltd., Pfizer Inc., Incyte Corporation, Sumitomo Pharma America Holdings, Inc., Lixte Biotechnology Holdings, Inc., Titan Pharmaceuticals, Inc., Active Biotech AB, Merck & Co., Inc., Amneal Pharmaceuticals, Inc., Roche Holding AG, Novartis AG, Chong Kun Dang Pharmaceutical Corp., CSPC Pharmaceutical Group Ltd., Ono Pharmaceutical Co., Ltd., BeiGene, Ltd., G1 Therapeutics, Inc.